Article
Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42
15 Jan 2020
Abstract excerpt
A key challenge in the implementation of anti-metastatics as cancer therapies is the multi-modal nature of cell migration, which allows tumour cells to evade the targeted inhibition of specific cell motility pathways. The nuclear factor-kappaB (NF-κB) co-factor B-cell lymphoma 3 (Bcl-3) has been implicated in breast cancer cell migration and metastasis, yet it remains to be determined exactly which cell motility...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
